Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

dj Orthopedics closes Aircast purchase:

This article was originally published in Clinica

Executive Summary

dj Orthopedics, the San Diego, California-based developer of orthopaedic rehabilitation and regeneration products, has completed its $290m acquisition of Aircast. The companies agreed to the transaction in March. Summit, New Jersey-based Aircast's range of orthopaedic products is expected to add leverage to that of its acquirer, while its VenaFlow vascular system for preventing post-surgical deep vein thrombosis will provide dj Orthopedics with a new market opportunity. The integration of the two companies' operations is forecast to generate cost savings of $15-20m from 2007 onwards.

You may also be interested in...



Changes To EU Pharma Reform: More Questions Than Answers?

In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.

Probiotics And Cold Remedies Boost Recordati In 2023

Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.

Falling Sales Force New Priorities At Roche

The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051371

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel